Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Harvard Business School
Express Scripts
Boehringer Ingelheim
Colorcon
Johnson and Johnson
Dow

Last Updated: January 24, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for Tivozanib

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What is the drug development status for Tivozanib?

Tivozanib is an investigational drug.

There have been 31 clinical trials for Tivozanib. The most recent clinical trial was a Phase 3 trial, which was initiated on March 1st 2010.

The most common disease conditions in clinical trials are Carcinoma, Carcinoma, Renal Cell, and Colorectal Neoplasms. The leading clinical trial sponsors are AVEO Pharmaceuticals, Inc., National Comprehensive Cancer Network, and Roswell Park Cancer Institute.

Recent Clinical Trials for Tivozanib
TitleSponsorPhase
A Study of Tivozanib in Combination With Durvalumab in Subjects With Untreated Advanced Hepatocellular CarcinomaAstraZenecaPhase 1/Phase 2
A Study of Tivozanib in Combination With Durvalumab in Subjects With Untreated Advanced Hepatocellular CarcinomaAVEO Pharmaceuticals, Inc.Phase 1/Phase 2
Phase 1/2 Study of Tivozanib in Combination With Nivolumab in Subjects With RCCBristol-Myers SquibbPhase 1/Phase 2

See all Tivozanib clinical trials

Clinical Trial Summary for Tivozanib

Top disease conditions for Tivozanib
Top clinical trial sponsors for Tivozanib

See all Tivozanib clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
AstraZeneca
McKinsey
Harvard Business School
Colorcon
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.